Keyphrases
Adult T-cell Leukemia
75%
Integrin
75%
Tumor Growth
72%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
65%
Breast Cancer
63%
Bone Loss
61%
Tumor
58%
Granulocyte Colony-stimulating Factor (G-CSF)
57%
Multiple Myeloma
48%
Myeloma Cells
48%
Targeted Therapy
48%
Viral Oncogenes
48%
Bone Metastasis
47%
Macrophages
47%
Mouse Model
45%
Pathologic
36%
Triple-negative Breast Cancer
36%
Nanotherapeutics
33%
Bone Tumor
33%
Tumor Cells
32%
Jurkat
32%
Allogeneic Donors
32%
Scoring Model
32%
T-cell Malignancies
32%
Chemotherapy-induced
30%
Parathyroid Hormone-related Protein (PTHrP)
29%
Metastatic Breast Cancer
27%
Human Mesenchymal Stem Cells (hMSCs)
27%
Hematopoietic Stem Cells
27%
Pro-tumor
27%
Human Adult
27%
Tumoral
27%
Metastasis
27%
Myeloid Cells
26%
Tumor-associated Macrophages
26%
Bortezomib Resistance
24%
Breast Cancer Bone Metastasis
24%
Cytokine Release Syndrome
24%
Molecular Targets
24%
Universal CAR-T
24%
Transferrin Receptor 1 (TfR1)
24%
Primary Breast Cancer
24%
Antitumor
24%
Immunosuppression
24%
CXCR4 Protein
24%
Chemoresistance
24%
Acetate Metabolism
24%
Tumor Growth in Vivo
24%
COVID-19
24%
Non-competitive
24%
Medicine and Dentistry
Neoplasm
100%
Tumor Progression
89%
Breast Cancer
74%
Adult T-Cell Leukemia/Lymphoma
62%
Human T-Lymphotropic Virus 1
61%
Integrin
53%
Metastatic Carcinoma
50%
Bone Metastasis
49%
Multiple Myeloma
48%
Virus Oncogene
48%
HBZ
48%
Bone Cancer
40%
Tumor Cell
39%
Osteolysis
39%
Macrophage
35%
In Vitro
34%
Triple Negative Breast Cancer
32%
Nanoparticle
28%
Metastatic Breast Cancer
27%
Targeted Therapy
27%
Immunosuppressive Treatment
27%
Tumor Microenvironment
27%
Malignant Neoplasm
26%
Myeloid Cell
26%
Bone Disease
25%
Granulocyte Macrophage Colony Stimulating Factor
24%
Drug Resistance
24%
Cancer Staging
24%
Immunosuppressive Drug
24%
Transferrin Receptor
24%
Nerve Cell Adhesion Molecule
24%
Imidazoline
24%
Arginase 1
24%
Epitope
24%
Drive
24%
COVID-19
24%
Bone Destruction
24%
Acetic Acid
24%
Heparanase
24%
Bortezomib
24%
Proteasome
24%
Myeloproliferative Neoplasm
24%
Prodrug
24%
Zoledronic Acid
24%
Hedgehog Signaling
24%
Tumor Model
24%
Hematopoietic Cell
24%
Tumor Suppressor Protein
24%
Fumagillin
24%
Triacylglycerol Lipase
24%